Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.

Overview of management issues for the Department of Commerce : hearing before the Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia of the Committee on Governmental Affairs, United States Senate, One Hundred Fifth Congress, first session, March 10, 1997.

United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia.

January 1997

Shipping list no.: 97-0265-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-51."Shipping list no.: 2002-0044-P.Distributed to some depository libraries in micro...

The administration's prescription drug proposal : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2001

"Serial 106-104."Shipping list no.: 2001-0213-P.Distributed to some depository libraries in microfic...

Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996.

United States. Congress. House. Committee on Small Business. Subcommittee on Government Programs.

"Serial no. 104-88."Shipping list no.: 97-0127-P.Distributed to some depository libraries in microfi...

Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991.

United States. Congress. Senate. Committee on Governmental Affairs. Ad Hoc Subcommittee on Consumer and Environmental Affairs.

January 1994

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Continued management concerns at the NIH : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, July 19, 1997.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1997

"Serial no. 105-26."Shipping list no.: 98-0002-P.Distributed to some depository libraries in microfi...

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 2001

"Serial no. 107-30."Shipping list no.: 2001-0304-P.Distributed to some depository libraries in micro...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations .
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0152-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Cutting edge issues in drug testing and drug treatment : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 5, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Security, International Affairs, and Criminal Justice.

January 1999

"Serial no. 105-182."Shipping list no.: 99-0178-P.Distributed to some depository libraries in microf...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Drug diversion investigations by the U.S. Drug Enforcement Administration : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, August 6, 1998.

United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime.

January 2000

"Serial no. 150."Shipping list no.: 2000-0188-P.Distributed to some depository libraries in microfic...

Oversight of U.S. regional counterdrug efforts : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, March 12, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Security, International Affairs, and Criminal Justice.

January 1998

Shipping list no.: 98-0345Distributed to some depository libraries in microfiche.Includes bibliograp...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Overview of management issues for the Department of Commerce : hearing before the Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia of the Committee on Governmental Affairs, United States Senate, One Hundred Fifth Congress, first session, March 10, 1997.

United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia.

January 1997

Shipping list no.: 97-0265-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-51."Shipping list no.: 2002-0044-P.Distributed to some depository libraries in micro...

The administration's prescription drug proposal : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2001

"Serial 106-104."Shipping list no.: 2001-0213-P.Distributed to some depository libraries in microfic...

Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996.

United States. Congress. House. Committee on Small Business. Subcommittee on Government Programs.

"Serial no. 104-88."Shipping list no.: 97-0127-P.Distributed to some depository libraries in microfi...

Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991.

United States. Congress. Senate. Committee on Governmental Affairs. Ad Hoc Subcommittee on Consumer and Environmental Affairs.

January 1994

Shipping list no.: 94-0359-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Continued management concerns at the NIH : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, July 19, 1997.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1997

"Serial no. 105-26."Shipping list no.: 98-0002-P.Distributed to some depository libraries in microfi...

Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 2001

"Serial no. 107-30."Shipping list no.: 2001-0304-P.Distributed to some depository libraries in micro...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations .
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0152-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Cutting edge issues in drug testing and drug treatment : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 5, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Security, International Affairs, and Criminal Justice.

January 1999

"Serial no. 105-182."Shipping list no.: 99-0178-P.Distributed to some depository libraries in microf...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Drug diversion investigations by the U.S. Drug Enforcement Administration : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, August 6, 1998.

United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime.

January 2000

"Serial no. 150."Shipping list no.: 2000-0188-P.Distributed to some depository libraries in microfic...

Oversight of U.S. regional counterdrug efforts : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, March 12, 1998.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Security, International Affairs, and Criminal Justice.

January 1998

Shipping list no.: 98-0345Distributed to some depository libraries in microfiche.Includes bibliograp...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Overview of management issues for the Department of Commerce : hearing before the Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia of the Committee on Governmental Affairs, United States Senate, One Hundred Fifth Congress, first session, March 10, 1997.

United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia.

January 1997

Shipping list no.: 97-0265-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-51."Shipping list no.: 2002-0044-P.Distributed to some depository libraries in micro...

The administration's prescription drug proposal : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2001

"Serial 106-104."Shipping list no.: 2001-0213-P.Distributed to some depository libraries in microfic...

Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.

Abstract

Extracted data

Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.

Abstract

Extracted data

Related items

Related items